Common Stock, Shares, Outstanding of Propanc Biopharma, Inc. from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Propanc Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q2 2011 to Q3 2025.
  • Propanc Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 12.8M shares, a 98.1% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 12.8M -675M -98.1% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 11.6M +11.6M 30 Jun 2025 10-Q 14 Nov 2025
Q1 2025 11.6M -98.1M -89.4% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 14.5K* -36.2M 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 688M +673M +4538% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 7.98K* -6.02M 30 Jun 2024 10-K 29 Sep 2025
Q1 2024 110M -2.51B -95.8% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 36.2M -1.21B -97.1% 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 14.8M -662M -97.8% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 6.03M +5.81M +2637% 30 Jun 2023 10-K 30 Sep 2024
Q1 2023 2.62B +2.54B +2983% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 1.25B +1.19B +2248% 31 Dec 2022 10-Q 10 Feb 2023
Q3 2022 677M +633M +1445% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 220K -13.8M -98.4% 30 Jun 2022 10-K 28 Sep 2023
Q1 2022 85M +80.1M +1611% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 53.1M +51.6M +3567% 31 Dec 2021 10-Q 14 Feb 2022
Q3 2021 43.8M -672M -93.9% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 14.1M +13.8M +5345% 30 Jun 2021 10-K 28 Sep 2022
Q1 2021 4.97M -13.5M -73.1% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 1.45M -788K -35.3% 31 Dec 2020 10-Q 12 Feb 2021
Q3 2020 716M +714M +61066% 30 Sep 2020 10-Q 16 Nov 2020
Q2 2020 258K -710K -73.3% 30 Jun 2020 10-K 28 Sep 2021
Q1 2020 18.5M -367M -95.2% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 2.23M -271M -99.2% 31 Dec 2019 10-Q 14 Feb 2020
Q3 2019 1.17M -174M -99.3% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 968K +875K 30 Jun 2019 10-K 01 Oct 2020
Q1 2019 385M +354M +1140% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 273M +256M +1447% 31 Dec 2018 10-Q 14 Feb 2019
Q3 2018 176M +169M +2540% 30 Sep 2018 10-Q 13 Nov 2018
Q2 2018 92.8K* -4.46M 30 Jun 2018 10-K 15 Oct 2019
Q1 2018 31.1M +27.3M +730% 31 Mar 2018 10-Q 10 May 2018
Q4 2017 17.7M -850M -98% 31 Dec 2017 10-Q 09 Feb 2018
Q3 2017 6.65M -787M -99.2% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 4.55M +1.64M +56.2% 30 Jun 2017 10-K 17 Sep 2018
Q1 2017 3.74M -599M -99.4% 31 Mar 2017 10-Q 08 May 2017
Q4 2016 867M +435M +100% 31 Dec 2016 10-Q 14 Feb 2017
Q3 2016 794M +446M +129% 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 2.91M -345M -99.2% 30 Jun 2016 10-K 28 Sep 2017
Q1 2016 602M +270M +81% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 433M +302M +231% 31 Dec 2015 10-Q 16 Feb 2016
Q3 2015 347M +265M +320% 30 Sep 2015 10-Q 16 Nov 2015
Q2 2015 347M +275M +378% 30 Jun 2015 10-K 28 Sep 2016
Q1 2015 333M +260M +358% 31 Mar 2015 10-Q 15 May 2015
Q4 2014 131M +58.1M +79.9% 31 Dec 2014 10-Q 17 Feb 2015
Q3 2014 82.8M +11M +15.3% 30 Sep 2014 10-Q 19 Nov 2014
Q2 2014 72.7M +2.05M +2.91% 30 Jun 2014 10-K 30 Sep 2015
Q1 2014 72.7M +2.05M +2.91% 31 Mar 2014 10-Q 20 May 2014
Q4 2013 72.7M -136K -0.19% 31 Dec 2013 10-Q 14 Feb 2014
Q3 2013 71.8M -876K -1.21% 30 Sep 2013 10-Q 14 Nov 2013
Q2 2013 70.6M -2.07M -2.85% 30 Jun 2013 10-K 14 Oct 2014
Q1 2013 70.6M -1.52M -2.11% 31 Mar 2013 10-Q 20 May 2013
Q4 2012 72.8M +817K +1.14% 31 Dec 2012 10-Q 20 Feb 2013
Q3 2012 72.7M 30 Sep 2012 10-Q 19 Nov 2012
Q2 2012 72.7M +790K +1.1% 30 Jun 2012 10-K 15 Oct 2013
Q1 2012 72.2M 31 Mar 2012 10-Q 21 May 2012
Q4 2011 72M 31 Dec 2011 10-Q/A 07 Mar 2012
Q2 2011 71.9M 30 Jun 2011 10-K 15 Oct 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.